Printer Friendly

Biolin Scientific in deal to buy Sophion Bioscience.


Swedish biotechnology instruments firm Biolin Scientific (STO:BLIN), owned by private equity firm Ratos, said today it would buy Danish automated patch clamping (APC) solutions provider Sophion Bioscience for DKK145m (USD28m/EUR19.4m) and earn-outs of DKK10m.

Sophion is being sold by Danish biopharmaceutical company NeuroSearch A/S (CPH:NEUR) and a number of venture capital firms, the buyer said in a press release. Ratos will provide SEK50m (USD7.9m/EUR5.5m) of the price, it said.

The acquisition will boost Biolina[euro](tm)s life science business and expand its customer base, the buyer explained.

The Copenhagen-based firm employs 50 staff and recorded sales of DKK83m and EBITA of DKK8m last year.

Completion is expected during the third quarter.Country: Denmark, Sector: BiotechnologyTarget: Sophion Bioscience A/SBuyer: Biolin Scientific AB, Ratos ABVendor: NeuroSearch A/S , Venture capital firmsDeal size in USD: 30mType: LBOStatus: AgreedComment: Deal size includes earn-outs.

COPYRIGHT 2011 Normans Media Ltd.
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 2011 Gale, Cengage Learning. All rights reserved.

Article Details
Printer friendly Cite/link Email Feedback
Publication:M & A Navigator
Date:Jul 6, 2011
Previous Article:Callidus Software announces acquisition of iCentera.
Next Article:Eagle Hospital Physicians expands with buy of PrimeDoc.

Terms of use | Privacy policy | Copyright © 2019 Farlex, Inc. | Feedback | For webmasters